Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Appointed director
Inv. presentation
Celldex Therapeutics, Inc. (CLDX) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/24/2015 8-K Investor presentation, Quarterly results
Docs: "CELLDEX REPORTS FOURTH QUARTER AND YEAR-END 2014 RESULTS",
"CELLDEX REPORTS FOURTH QUARTER AND YEAR-END 2014 RESULTS",
"Celldex's Rindopepimut Receives FDA Breakthrough Therapy Designation for the Treatment of Adult Patients with EGFRvIII-positive Glioblastoma",
"Celldex's Rindopepimut Receives FDA Breakthrough Therapy Designation for the Treatment of Adult Patients with EGFRvIII-positive Glioblastoma",
"Corporate Presentation"
11/25/2013 8-K Investor presentation
Docs: "Slide Presentation"
03/07/2013 8-K Form 8-K - Current report
01/07/2013 8-K Form 8-K - Current report
05/23/2012 8-K Investor presentation
Docs: "CELLDEX'S CDX-011 DEMONSTRATES HIGH RESPONSE RATES IN PATIENTS WITH METASTATIC BREAST CANCER EXPRESSING ELEVATED LEVELS OF GPNMB AND IN TRIPLE NEGATIVE DISEASE",
"Presentation of Celldex Therapeutics, Inc."

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy